Consolidated Statements of Cash Flows - USD ($)		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023
OPERATING ACTIVITIES:
Net loss	[1]	$ (11,890,843)	$ (18,482,880)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	[1]	1,135,228	1,492,261
Change in allowance for credit losses	[1]		15,425
Loss on disposal of assets	[1]		2,073
Loss on notes receivable settlement	[1]		10,931
Loss on vendor settlement	[1]		91,291
Issuance common stocks for services	[1]		150,000
Gain on sale of building	[1]	(205,146)
Amortization of right-of-use asset	[1]	2,475,136	2,590,325
Loss on investment	[1]	1,336	8,485
Write-down of obsolete and slow-moving inventory	[1]	1,966,472	2,471,653
Stock-based compensation expense	[1]	4,619,500	3,430,250
Change in contingent consideration	[1]		(774,900)
Non-cash interest expense	[1]	72,250	32,000
Loss on warrant liability extinguishment	[1]	1,888,889
Impairment of Goodwill	[1]		6,104,000
Changes in operating assets and liabilities:
Accounts receivable	[1]	(253,460)	(87,781)
Inventories	[1]	(1,907,935)	(2,032,838)
Prepaid expenses and vendor deposits	[1]	1,283,098	(177,374)
Due from related party	[1]	(296,178)
Other current assets	[1]	27,898	1,068,610
Other assets	[1]	42,347	(145,189)
Accounts payable and accrued liabilities	[1]	(82,853)	1,974,429
Contract liabilities	[1]	(156,904)	(21,604)
Lease liability	[1]	(2,374,464)	(2,458,303)
NET CASH USED IN OPERATING ACTIVITIES	[1]	(3,655,629)	(4,739,136)
INVESTING ACTIVITIES:
Payment for acquisition	[1]	(5,475,000)	(750,000)
Proceeds from sale of Saugerties building	[1]	749,000
Collection of note receivable	[1]		178,294
Purchases of patent	[1]		(12,500)
Purchases of property and equipment	[1]	(192,865)	(184,349)
NET CASH USED IN INVESTING ACTIVITIES	[1]	(4,918,865)	(768,555)
FINANCING ACTIVITIES:
Proceeds from acquisition loan	[1]	7,500,000
Payments for deferred offering costs	[1]		(833,767)
Principal payments on loan payable	[1]	(349,082)	(558,095)
Proceeds from security purchase agreement	[1]	1,700,000
Due to related party	[1]	486,446
Net transfers to HCWC related to Spin-Off	[1]	(4,650,389)
Payment for series E preferred stock redemption	[1]		(12,003,753)
Payment of induced conversions of preferred stock	[1]		(152,500)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	[1]	4,686,975	(13,548,115)
NET DECREASE IN CASH AND RESTRICTED CASH	[1]	(3,887,519)	(19,055,806)
CASH AND RESTRICTED CASH — BEGINNING OF YEAR	[1]	5,634,318	24,690,124
CASH AND RESTRICTED CASH — END OF YEAR	[1]	1,746,799	5,634,318
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid for interest	[1]	497,028	205,449
Cash paid for income tax	[1]
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock in connection with series E preferred stock conversion	[1]		1,585,000
1% stated value reduction on preferred stock redemption	[1]		22,222
Non-cash deferred offering cost	[1]		335,001
Issuance of promissory note in connection with acquisition	[1]		718,000
Lease acquired	[1]	$ 4,609,608	$ 1,325,409

[1] The cash flows related to discontinued operations have not been segregated. Accordingly, the Consolidated Statements of Cash Flows include the results of continuing and discontinued operations. See Note 2 for cash flows related to Discontinued Operations.